Monashee Investment Management as of Dec. 31, 2025
Portfolio Holdings for Monashee Investment Management
Monashee Investment Management holds 40 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Structure Therapeutics Sponsored Ads (GPCR) | 8.8 | $16M | 225k | 69.55 | |
| Medline Com Cl A (MDLN) | 7.1 | $13M | 300k | 42.00 | |
| Sofi Technologies (SOFI) | 5.9 | $11M | 400k | 26.18 | |
| Ul Solutions Class A Com Shs (ULS) | 5.8 | $10M | 130k | 78.86 | |
| Insmed Com Par $.01 (INSM) | 4.9 | $8.7M | 50k | 174.04 | |
| Terns Pharmaceuticals (TERN) | 4.5 | $8.0M | 197k | 40.40 | |
| Kymera Therapeutics (KYMR) | 4.4 | $7.8M | 100k | 77.81 | |
| Miami Intl Hldgs (MIAX) | 4.4 | $7.8M | 175k | 44.38 | |
| Bridgebio Pharma (BBIO) | 4.3 | $7.6M | 100k | 76.49 | |
| Solid Biosciences Com New (SLDB) | 4.3 | $7.6M | 1.3M | 5.64 | |
| Legence Corp Cl A (LGN) | 3.3 | $5.9M | 138k | 43.04 | |
| Immunome (IMNM) | 3.3 | $5.9M | 275k | 21.48 | |
| Itt (ITT) | 3.1 | $5.6M | 32k | 173.51 | |
| Compass Therapeutics (CMPX) | 3.0 | $5.4M | 1.0M | 5.37 | |
| Cytokinetics Com New (CYTK) | 2.7 | $4.8M | 75k | 63.54 | |
| Wealthfront Corp (WLTH) | 2.3 | $4.1M | 300k | 13.59 | |
| Nektar Therapeutics Com New (NKTR) | 2.2 | $4.0M | 94k | 42.28 | |
| Southern Unit 12/15/2028 (SOMN) | 2.2 | $3.8M | 76k | 50.36 | |
| Adt (ADT) | 1.8 | $3.2M | 400k | 8.07 | |
| Evommune Com Shs (EVMN) | 1.8 | $3.1M | 183k | 17.12 | |
| Gossamer Bio (GOSS) | 1.7 | $3.1M | 1.0M | 3.10 | |
| Novanta Unit 11/01/2028 (NOVTU) | 1.7 | $3.1M | 56k | 54.98 | |
| Lumexa Imaging Holdings (LMRI) | 1.6 | $2.8M | 150k | 18.50 | |
| Engene Holdings (ENGN) | 1.5 | $2.7M | 295k | 9.03 | |
| Ambiq Micro Common Stock (AMBQ) | 1.4 | $2.4M | 85k | 28.50 | |
| Dyne Therapeutics (DYN) | 1.3 | $2.2M | 115k | 19.56 | |
| Whitefiber SHS (WYFI) | 1.2 | $2.2M | 140k | 15.80 | |
| Grupo Aeromexico Sab De Cv Sponsored Ads (AERO) | 1.1 | $2.0M | 92k | 21.96 | |
| Eqv Ventures Ac Corp. Ii Unit 06/30/2032 (EVAC.U) | 1.1 | $2.0M | 198k | 10.11 | |
| Kyverna Therapeutics (KYTX) | 1.0 | $1.8M | 195k | 9.40 | |
| Immatics SHS (IMTX) | 0.9 | $1.7M | 160k | 10.50 | |
| Contineum Therapeutics Cl A (CTNM) | 0.9 | $1.6M | 137k | 11.43 | |
| Denali Therapeutics (DNLI) | 0.9 | $1.5M | 92k | 16.51 | |
| Gossamer Bio Note 5.000% 6/0 (Principal) | 0.7 | $1.3M | 1.9M | 0.68 | |
| Vera Therapeutics Cl A (VERA) | 0.7 | $1.2M | 23k | 50.64 | |
| Lightpath Technologies Com Cl A (LPTH) | 0.6 | $1.1M | 100k | 10.80 | |
| Biodesix (BDSX) | 0.4 | $764k | 112k | 6.80 | |
| Protara Therapeutics Com Stk (TARA) | 0.4 | $666k | 125k | 5.33 | |
| Imagenebio (IMA) | 0.4 | $632k | 92k | 6.90 | |
| Ibio Com New (IBIO) | 0.3 | $531k | 275k | 1.93 |
